Screening Anticancer Drugs with NCI Lines

The National Cancer Institute (NCI) cell line panel has revolutionized cancer drug discovery, offering researchers a standardized platform for evaluating potential therapeutic compounds. At Cytion, we provide many of these essential cell lines, enabling researchers to conduct comprehensive anticancer drug screening studies with validated, high-quality cellular models.

Key Takeaways

Research Applications	• High-throughput drug screening • Mechanism of action studies • Drug resistance evaluation
Cell Line Diversity	• Multiple cancer types represented • Various tissue origins • Different genetic profiles
Validation	• Authentication guaranteed • Mycoplasma-free certification • Documented passage history

Research Applications in Drug Discovery

The NCI-60 cell line panel represents a powerful tool in cancer drug discovery, offering researchers a standardized platform for initial drug screening. Key cell lines like A549 cells for lung cancer and MCF-7 cells for breast cancer research have become cornerstone models in high-throughput screening campaigns. These validated cell lines enable researchers to rapidly assess thousands of compounds for anticancer activity.

Our validated cell lines, including HepG2 cells and LNCaP cells, are extensively used in drug discovery pipelines to:

Evaluate dose-response relationships
Determine IC50 values
Assess cancer-type specificity
Study cytotoxicity profiles

Each cell line in our portfolio undergoes rigorous authentication testing and mycoplasma screening, ensuring reliable and reproducible results in your drug discovery programs. Our standardized protocols and detailed documentation support Good Laboratory Practice (GLP) compliance in drug development workflows.

Comprehensive Cell Line Diversity

Cancer heterogeneity demands diverse cellular models. Our NCI line collection spans multiple tissue origins and genetic backgrounds, providing researchers with comprehensive screening capabilities. From breast cancer to brain cancer models, each cell line offers unique insights into cancer biology.

Key Tissue Types Available:

• Lung Cancer • Liver Cancer • Prostate Cancer • Intestinal Cancer

Featured Cell Lines:

• HeLa cells - Cervical cancer • HepG2 cells - Liver cancer • LNCaP cells - Prostate cancer • A549 cells - Lung cancer

Each cell line in our portfolio represents distinct molecular profiles and drug response patterns. For instance, our MCF-7 cells are widely used for hormone-dependent breast cancer studies, while MDA-MB-231 cells represent triple-negative breast cancer models. This diversity enables researchers to:

Compare drug responses across multiple cancer types
Identify tissue-specific drug sensitivities
Study mechanism of action in different cellular contexts
Evaluate targeted therapy approaches

Quality Validation and Authentication

At Cytion, we understand that cell line authentication is crucial for reliable research outcomes. Every NCI cell line in our portfolio undergoes comprehensive validation protocols, ensuring the highest standards of quality and reproducibility.

Authentication Testing

All cell lines undergo authentication testing, including STR profiling and species verification, providing researchers with confirmed cell line identity.

Contamination Screening

Regular mycoplasma testing and sterility checks ensure our cell lines are free from biological contamination.

Growth Characteristics

Each batch is monitored for proper morphology, growth rates, and phenotypic stability across passages.

To maintain the highest quality standards in your drug screening programs, we recommend regular cell line authentication and contamination testing. Our cell banking services can help establish and maintain validated master cell banks for your critical cell lines.

Advancing Cancer Research Through Validated Cell Models

The success of anticancer drug screening programs relies heavily on the quality and diversity of cell line models. At Cytion, we provide researchers with authenticated NCI cell lines, comprehensive validation services, and expert technical support to accelerate their drug discovery programs.

Ready to advance your cancer drug screening research? Contact our team for:

Custom cell line panels for your specific research needs
Technical support and protocol optimization
Authentication and quality control services

Contact our scientific team →